Biology subjects

Smith, K. S.

Publications and source records attributed to Smith, K. S..

3 recordsLinked to original sources

bioRxiv2018

The dorsolateral striatum regulates habits by way of performance vigor when actions are initiated

Despite clear evidence linking basal ganglia control to habits, it remains unclear through what mechanisms this control occurs. Here, we demonstrate that a key function of the dorsolateral striatum (DLS) is to regulate the vigor of a learned behavior at the moment of initiation in a habit-promoting manner. Shifts in vigor by phasic DLS perturbations coincide closely with how outcome-insensitive (i.e., habitual) the behaviors are in both response-based and cue-based task situations. Surprisingly, the control over habit strength by way of changes in vigor occurs without consistent changes in accuracy, suggesting that mechanisms controlling habit and vigor are dissociable from performance governed task rules. Finally, we show that increased DLS activity improves vigor preferentially when learned outcome values are stable, while reduced DLS activity dampens vigor preferentially when outcome values change. These data indicate that improving action vigor could be a principle route by which the basal ganglia facilitate habits.

animal behavior and cognition↗

bioRxiv2018

Identification of rare-disease genes in diverse undiagnosed cases using whole blood transcriptome sequencing and large control cohorts

RNA sequencing (RNA-seq) is a complementary approach for Mendelian disease diagnosis for patients in whom exome-sequencing is not informative. For both rare neuromuscular and mitochondrial disorders, its application has improved diagnostic rates. However, the generalizability of this approach to diverse Mendelian diseases has yet to be evaluated. We sequenced whole blood RNA from 56 cases with undiagnosed rare diseases spanning 11 diverse disease categories to evaluate the general application of RNA-seq to Mendelian disease diagnosis. We developed a robust approach to compare rare disease cases to existing large sets of RNA-seq controls (N=1,594 external and N=31 family-based controls) and demonstrated the substantial impacts of gene and variant filtering strategies on disease gene identification when combined with RNA-seq. Across our cohort, we observed that RNA-seq yields a 8.5% diagnostic rate. These diagnoses included diseases where blood would not intuitively reflect evidence of disease. We identified RARS2 as an under-expression outlier containing compound heterozygous pathogenic variants for an individual exhibiting profound global developmental delay, seizures, microcephaly, hypotonia, and progressive scoliosis. We also identified a new splicing junction in KCTD7 for an individual with global developmental delay, loss of milestones, tremors and seizures. Our study provides a broad evaluation of blood RNA-seq for the diagnosis of rare disease.

genomics↗

bioRxiv2017

A computational framework for detecting signatures of accelerated somatic evolution in cancer genomes

By accumulation of somatic mutations, cancer genomes evolve, diverging away from the genome of the host. It remains unclear to what extent somatic evolutionary divergence is comparable across different regions of the cancer genome versus concentrated in specific genomic elements. We present a novel computational framework, SASE-mapper, to identify genomic regions that show signatures of accelerated somatic evolution (SASE) in a subset of samples in a cohort, marked by accumulation of an excess of somatic mutations compared to that expected based on local, context-aware background mutation rates in the cancer genomes. Analyzing tumor whole genome sequencing data for 365 samples from 5 cohorts we detect recurrent SASE at a genome-wide scale. The SASEs were enriched for genomic elements associated with active chromatin, and regulatory regions of several known cancer genes had SASE in multiple cohorts. Regions with SASE carried specific mutagenic signatures and often co-localized within the 3D nuclear space suggesting their common basis. A subset of SASEs was frequently associated with regulatory changes in key cancer pathways and also poor clinical outcome. While the SASE-associated mutations were not necessarily recurrent at base-pair resolution, the SASEs recurrently targeted same functional regions, with similar consequences. It is likely that regulatory redundancy and plasticity promote prevalence of SASE-like patterns in the cancer genomes.

bioinformatics↗